Glucagon biosynthesis

HOUR) Plasma Rate of Purine Hepatic Glucagon Biosynthesis Cyclic AMP (AV SEM) de novo (AV SEM) (pmole/ml) (CPM/jUmole adenine) (pmole/g prot) Hepatic PP-ribose-P° (AV SEM) (nmole/g prot) ... 

Biosynthesis and degradation of glycosaminoglycans biosynthesis of collagen, mineralization and demineralization of bone. Fatty acid synthesis and triglyceride storage in adipocytes promoted by insulin and triglyceride hydrolysis and fatty acid release stimulated by glucagon and adrenaline (epinephrine). 

Phenanthrolines affect the biosynthesis of collagen391-3 2 510-514 and isoprenoids515 and various metabolic processes.516-520 It inhibits anaerobic fixation of nitrogen5 and the inactivation of glucagon by microsomal membranes.522... 

Pyruvate dehydrogenase, especially in the adipose tissue, is stimulated by a high insulin/glucagon ratio. This leads to the production of acetyl-CoA, which may enter the Krebs cycle in the fed state. The more likely possibility is the biosynthesis of fatty acids from acetyl-CoA. The latter requires NADPH, and for this reason, the hexose monophosphate shunt is also activated. 

Even though AMP, not cAMP, may be the protein kinase activator, glucagon causes its activation and insulin, inactivation. Details on such hormone effects are lacking. Also recall that malonyl-CoA inhibits palmitoyl-CoA-camitine acyltrans ferase, the rate-controlling enzyme in the /3-oxidation process. Thus, lipid oxidation is inhibited in an environment that favors lipid synthesis, as in the fed state, whereas lipid biosynthesis is inhibited in an environment favoring lipid oxidation, as in fasting. 

Fatty add synthetase is not controlled directly by phosphorylation however, insulin, glucagon, and thyroxine have an effect on its activity by controlling its cellular concentration. Both insulin and thyroxine increase the biosynthesis of the enzyme, whereas glucagon is inhibitory. Thyroxine and glucagon appear to regulate the biosynthesis at the transcription level, whereas insulin affects the enzyme activity at the translation level. It has no effect on cellular fatty add synthetase mRNA concentration. In summary, fatty add synthetase levels are up in the fed state and down in the fasting state. 

Situations in which the blood insulin/glucagon ratio is higher than normal lead to fatty acid and cholesterol biosynthesis, whereas low insulin/glucagon ratios are characterized by lipolysis, increased activity of the /3-oxidation pathway, and a low level of cholesterol biosynthetic activity. Enzymes that are either activated by insulin or derepressed by low glucagon levels are lipoprotein lipase, which... 

Figure 6.5 Regulation of HMG-CoA reductase. HMG-CoA reductase is active in the dephospho-rylated state phosphorylation (inhibition) is catalysed by reductase kinase, an enzyme whose activity is also regulated by phosphorylation by reductase kinase kinase. Hormones such as glucagon and adrenalin (epinephrine) negatively affect cholesterol biosynthesis by increasing the activity of the inhibitor of phosphoprotein phosphatase-1, PPI-1, (by raising cAMP levels) and so reducing the activation of HMG-CoA reductase. Conversely, insulin stimulates the removal of phosphates (and lowers cAMP levels), and thereby activates HMG-CoA reductase activity. Additional regulation of HMG-CoA reductase occurs through an inhibition of synthesis of the enzyme by elevation in intracellular cholesterol levels.

---